As of the conclusion of the prior year, the firm, with its linked enterprises holding assets in the U.S., declared outstanding liabilities amounting to $335 billion.
As debate around the coronavirus "lab leak hypothesis" continues, fueling speculation as to the extent human intention or error contributed to the COVID-19 pandemic, questions are raised about whether Pfizer's laboratories in Mumbai and Johannesburg are implicated in the emergence of new COVID variants like Eris.